The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Point-of-Care Infectious Disease Diagnostics & Testing-Global Market Insights and Sales Trends 2025
Synopsis
A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management.
The global Point-of-Care Infectious Disease Diagnostics & Testing market size is expected to reach US$ 2764.3 million by 2029, growing at a CAGR of 4.4% from 2023 to 2029. The market is mainly driven by the significant applications of Point-of-Care Infectious Disease Diagnostics & Testing in various end use industries. The expanding demands from the Hospitals, Clinics, Home and Assisted Living Healthcare Facilities, are propelling Point-of-Care Infectious Disease Diagnostics & Testing market. HIV POC, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Clostridium difficile POC segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Point-of-Care Infectious Disease Diagnostics & Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Point-of-Care Infectious Disease Diagnostics & Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Point-of-Care Infectious Disease Diagnostics & Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Point-of-Care Infectious Disease Diagnostics & Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Point-of-Care Infectious Disease Diagnostics & Testing covered in this report include Abbott, Thermo Fisher Scientific Inc, Roche, Siemens Healthineers, BD & Company, Chembio Diagnostics Inc., Trinity Biotech, Cardinal Health and Quest Diagnostics Inc., etc.
The global Point-of-Care Infectious Disease Diagnostics & Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Thermo Fisher Scientific Inc
Roche
Siemens Healthineers
BD & Company
Chembio Diagnostics Inc.
Trinity Biotech
Cardinal Health
Quest Diagnostics Inc.
Bio-Rad Labs Inc.
bioMérieux SA
Sight Diagnostics Ltd.
Gene POC
Trivitron Healthcare
OJ-Bio Ltd.
Ortho-Clinical Diagnostics
Global Point-of-Care Infectious Disease Diagnostics & Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Point-of-Care Infectious Disease Diagnostics & Testing market, Segment by Type:
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
Other Infectious Disease POC
Global Point-of-Care Infectious Disease Diagnostics & Testing market, by Application
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Point-of-Care Infectious Disease Diagnostics & Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management.
The global Point-of-Care Infectious Disease Diagnostics & Testing market size is expected to reach US$ 2764.3 million by 2029, growing at a CAGR of 4.4% from 2023 to 2029. The market is mainly driven by the significant applications of Point-of-Care Infectious Disease Diagnostics & Testing in various end use industries. The expanding demands from the Hospitals, Clinics, Home and Assisted Living Healthcare Facilities, are propelling Point-of-Care Infectious Disease Diagnostics & Testing market. HIV POC, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Clostridium difficile POC segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Point-of-Care Infectious Disease Diagnostics & Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Point-of-Care Infectious Disease Diagnostics & Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Point-of-Care Infectious Disease Diagnostics & Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Point-of-Care Infectious Disease Diagnostics & Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Point-of-Care Infectious Disease Diagnostics & Testing covered in this report include Abbott, Thermo Fisher Scientific Inc, Roche, Siemens Healthineers, BD & Company, Chembio Diagnostics Inc., Trinity Biotech, Cardinal Health and Quest Diagnostics Inc., etc.
The global Point-of-Care Infectious Disease Diagnostics & Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Thermo Fisher Scientific Inc
Roche
Siemens Healthineers
BD & Company
Chembio Diagnostics Inc.
Trinity Biotech
Cardinal Health
Quest Diagnostics Inc.
Bio-Rad Labs Inc.
bioMérieux SA
Sight Diagnostics Ltd.
Gene POC
Trivitron Healthcare
OJ-Bio Ltd.
Ortho-Clinical Diagnostics
Global Point-of-Care Infectious Disease Diagnostics & Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Point-of-Care Infectious Disease Diagnostics & Testing market, Segment by Type:
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
Other Infectious Disease POC
Global Point-of-Care Infectious Disease Diagnostics & Testing market, by Application
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Point-of-Care Infectious Disease Diagnostics & Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Point-of-Care Infectious Disease Diagnostics & Testing
1.1 Point-of-Care Infectious Disease Diagnostics & Testing Market Overview
1.1.1 Point-of-Care Infectious Disease Diagnostics & Testing Product Scope
1.1.2 Point-of-Care Infectious Disease Diagnostics & Testing Market Status and Outlook
1.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2018-2029)
1.4 Global Point-of-Care Infectious Disease Diagnostics & Testing Historic Market Size by Region (2018-2023)
1.5 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2018-2029)
1.6.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2018-2029)
1.6.2 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2018-2029)
1.6.4 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2018-2029)
2 Point-of-Care Infectious Disease Diagnostics & Testing Market by Type
2.1 Introduction
2.1.1 HIV POC
2.1.2 Clostridium difficile POC
2.1.3 HBV POC
2.1.4 Pneumonia or Streptococcus associated infections
2.1.5 Respiratory syncytial virus (RSV) POC
2.1.6 HPV POC
2.1.7 Influenza/Flu POC
2.1.8 Other Infectious Disease POC
2.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Point-of-Care Infectious Disease Diagnostics & Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Revenue Breakdown by Type (2018-2029)
3 Point-of-Care Infectious Disease Diagnostics & Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Home
3.1.4 Assisted Living Healthcare Facilities
3.1.5 Laboratories
3.1.6 Others
3.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Point-of-Care Infectious Disease Diagnostics & Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Revenue Breakdown by Application (2018-2029)
4 Point-of-Care Infectious Disease Diagnostics & Testing Competition Analysis by Players
4.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Point-of-Care Infectious Disease Diagnostics & Testing as of 2022)
4.3 Date of Key Players Enter into Point-of-Care Infectious Disease Diagnostics & Testing Market
4.4 Global Top Players Point-of-Care Infectious Disease Diagnostics & Testing Headquarters and Area Served
4.5 Key Players Point-of-Care Infectious Disease Diagnostics & Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Point-of-Care Infectious Disease Diagnostics & Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
5.1.4 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 Thermo Fisher Scientific Inc
5.2.1 Thermo Fisher Scientific Inc Profile
5.2.2 Thermo Fisher Scientific Inc Main Business
5.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Inc Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
5.3.4 Roche Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Siemens Healthineers Recent Developments
5.4 Siemens Healthineers
5.4.1 Siemens Healthineers Profile
5.4.2 Siemens Healthineers Main Business
5.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
5.4.4 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Siemens Healthineers Recent Developments
5.5 BD & Company
5.5.1 BD & Company Profile
5.5.2 BD & Company Main Business
5.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
5.5.4 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.5.5 BD & Company Recent Developments
5.6 Chembio Diagnostics Inc.
5.6.1 Chembio Diagnostics Inc. Profile
5.6.2 Chembio Diagnostics Inc. Main Business
5.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
5.6.4 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Chembio Diagnostics Inc. Recent Developments
5.7 Trinity Biotech
5.7.1 Trinity Biotech Profile
5.7.2 Trinity Biotech Main Business
5.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
5.7.4 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Trinity Biotech Recent Developments
5.8 Cardinal Health
5.8.1 Cardinal Health Profile
5.8.2 Cardinal Health Main Business
5.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
5.8.4 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Cardinal Health Recent Developments
5.9 Quest Diagnostics Inc.
5.9.1 Quest Diagnostics Inc. Profile
5.9.2 Quest Diagnostics Inc. Main Business
5.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
5.9.4 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Quest Diagnostics Inc. Recent Developments
5.10 Bio-Rad Labs Inc.
5.10.1 Bio-Rad Labs Inc. Profile
5.10.2 Bio-Rad Labs Inc. Main Business
5.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
5.10.4 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Bio-Rad Labs Inc. Recent Developments
5.11 bioMérieux SA
5.11.1 bioMérieux SA Profile
5.11.2 bioMérieux SA Main Business
5.11.3 bioMérieux SA Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
5.11.4 bioMérieux SA Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.11.5 bioMérieux SA Recent Developments
5.12 Sight Diagnostics Ltd.
5.12.1 Sight Diagnostics Ltd. Profile
5.12.2 Sight Diagnostics Ltd. Main Business
5.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
5.12.4 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Sight Diagnostics Ltd. Recent Developments
5.13 Gene POC
5.13.1 Gene POC Profile
5.13.2 Gene POC Main Business
5.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
5.13.4 Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.13.5 Gene POC Recent Developments
5.14 Trivitron Healthcare
5.14.1 Trivitron Healthcare Profile
5.14.2 Trivitron Healthcare Main Business
5.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
5.14.4 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.14.5 Trivitron Healthcare Recent Developments
5.15 OJ-Bio Ltd.
5.15.1 OJ-Bio Ltd. Profile
5.15.2 OJ-Bio Ltd. Main Business
5.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
5.15.4 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.15.5 OJ-Bio Ltd. Recent Developments
5.16 Ortho-Clinical Diagnostics
5.16.1 Ortho-Clinical Diagnostics Profile
5.16.2 Ortho-Clinical Diagnostics Main Business
5.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
5.16.4 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2018-2023)
5.16.5 Ortho-Clinical Diagnostics Recent Developments
6 North America
6.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Point-of-Care Infectious Disease Diagnostics & Testing Market Dynamics
11.1 Point-of-Care Infectious Disease Diagnostics & Testing Industry Trends
11.2 Point-of-Care Infectious Disease Diagnostics & Testing Market Drivers
11.3 Point-of-Care Infectious Disease Diagnostics & Testing Market Challenges
11.4 Point-of-Care Infectious Disease Diagnostics & Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
